Saturday, November 26, 2011

New cancer drug delivery system performs well in latest clinical trial

Better delivery system apparently found for experimental ovarian cancer drug, GAP-107B8.

Although the drug is still in pre-clinical development, researchers are hopeful it may eventually be used to fight pancreatic, colorectal, gastric, and liver cancers, too.

Click-on the headline link below to read the report I found on ProactiveInvestors.com:

PharmaGap cancer drug achieves 3 key clinical testing elements in pre-clinical trial

Feel good and keep smiling!  Pat

No comments:

Post a Comment